Barnes & Noble Stock Continues Plunge After Another Weak Quarter

However, near-term options traders have been seemingly upbeat

by Emma Duncan

Published on Sep 6, 2018 at 9:52 AM

The Coca-Cola Co
The Coca-Cola Co
The Coca-Cola Co
The Coca-Cola Co
The Coca-Cola Co

Shares of Barnes & Noble, Inc. (NYSE:BKS) are down 5% at $4.70 in early trading after the company announced a bigger-than-expected fiscal first-quarter loss and massive drop in comparable sales. In the earnings call, the book seller admitted that it understands cutting costs alone is not a "path to long term viability of any retail business." 

Barnes & Noble stock has struggled on a long-term basis, and has been unable to recover from a massive bear gap in January that paved the way to its March 1 record low of $4.10. Since then, both of BKS' noteworthy breakout attempts have been quickly capped by the 320-day moving average, pushing the retailer to its 30% year-to-date deficit. 

Digging into options, near-term traders remain seemingly upbeat, with the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.19 ranking in the low 21st annual percentile. In other words, call open interest for options expiring within three months outweighs put open interest by a wider-than-usual margin.

Lastly, short interest on Barnes & Noble stock rose 11.7% during the past two reporting periods, and now represents nearly 14.4% of the retailer's total available float. This means that at BKS' average daily trading volume, it would take shorts over two weeks to buy back their bearish bets.

a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.
Merck Makes Big Move For Cancer Drug Developer
MRK is fresh off a 19-year high from Friday
ATVI Stock Gets Price-Target Bump as it Rides Chart Support
Short interest on Activision Blizzard is at a 3-year high
The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.